Results 41 to 50 of about 60,692 (294)

Diabetic Ketoacidosis in Pediatric Patients [PDF]

open access: yes, 2022
Diabetic Ketoacidosis in Pediatric Patients Jarrod Genther Otterbein University NURS 6810- Advanced Pathophysiology Deana Batross, DNP & Shivani Bhatnagar, DNP July 29, 2022 Diabetic Ketoacidosis in Pediatric Patients Abstract Diabetic ketoacidosis is a ...
Genther, Jarrod
core   +1 more source

Novel diabetes drugs and the cardiovascular specialist [PDF]

open access: yes, 2017
Recently, treatment with 2 newer classes of type 2 diabetes drugs were found to reduce events in patients with diabetes and cardiovascular (CV) disease, a group common in cardiology clinics.
Januzzi Jr., James L.   +3 more
core   +1 more source

Epidemiological characteristics and lethality of adults with diabetic ketoacidosis treated in a uni-versity hospital in Colombia

open access: yesIatreia, 2021
Importance: Ketoacidosis is one of the most serious complications of diabetes. Few studies in Latin America describe the clinical profile and outcomes of adults with diabetic ketoacidosis.
Sierra-Vargas, Elsy Cristina   +5 more
doaj   +1 more source

A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus. [PDF]

open access: yesDiabetes Obes Metab
Abstract Aim To understand the existing literature on the epidemiology and clinical, humanistic, and economic burden of diabetic ketoacidosis (DKA) in people living with type 2 diabetes mellitus (T2DM). Materials and Methods MEDLINE, Embase and the Cochrane library were systematically searched for studies published between 1 January 2014 and 14 ...
Wysham C   +4 more
europepmc   +2 more sources

Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Related Diabetic Ketoacidosis [PDF]

open access: yes, 2019
Diabetic ketoacidosis is a rare but serious and life-threatening acute complication of diabetes mellitus. It is characterized by ketoacidosis with other findings and should be treated immediately. In this case, a 33-year-old diabetic patient who admitted
Ahbab, Suleyman   +3 more
core   +2 more sources

Concomitant Use of Oral Anticoagulants With Oral Dipeptidyl Peptidase‐4 Inhibitors and Serious Bleeding Events

open access: yesClinical Pharmacology &Therapeutics, Volume 117, Issue 4, Page 1012-1016, April 2025.
In a prior screening study, saxagliptin, a dipeptidyl peptidase‐4 inhibitor (DPP‐4i), was found to have an increased rate of serious bleeding when used concomitantly with several oral anticoagulants (OACs). We aimed to confirm or refute the associations between concomitant use of individual OACs and DPP‐4is and serious bleeding in a large US database ...
Thanh Phuong Pham Nguyen   +8 more
wiley   +1 more source

Increased risk of death following recurrent ketoacidosis admissions: a Brazilian cohort study of young adults with type 1 diabetes

open access: yesDiabetology & Metabolic Syndrome, 2023
Background Recurrent DKA (rDKA) remains an acute type 1 diabetes complication even in post-insulin era. This study aimed to analyze the predictors and effects of rDKA on the mortality of patients with type 1 diabetes.
Sarah S. Santos   +5 more
doaj   +1 more source

Clinical profile and outcomes of paediatric patients with diabetic ketoacidosis at a tertiary care hospital in Pakistan [PDF]

open access: yes, 2011
OBJECTIVES: This study aims to present an experience in the management and clinical features of 88 children presenting with diabetic ketoacidosis (DKA) from Pakistan.
Humayun, Khadija Nuzhat   +5 more
core   +1 more source

Diabetic ketoacidosis complicated by the use of ecstasy: a case report [PDF]

open access: yes, 2010
Introduction Ecstasy (3,4-methylenedioxymethamphetamin), a hallucinogenic amphetamine, is often used by young people, especially at 'raves'. This illicit drug can cause many metabolic changes and its use, when associated with prolonged exercise, may ...
A Gamma   +17 more
core   +3 more sources

Diabetes Link: Platform for Self-Control and Monitoring People with Diabetes [PDF]

open access: yes, 2020
Diabetes Mellitus (DM) is a chronic disease characterized by an increase in blood glucose (sugar) above normal levels and it appears when human body is not able to produce enough insulin to cover the peripheral tissue demand. Nowadays, DM affects the 8.5% of the world's population and, even though no cure for it has been found, an adequate monitoring ...
arxiv   +1 more source

Home - About - Disclaimer - Privacy